rs147318592

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2

The NM_001365951.3(KIF1B):​c.3645G>A​(p.Pro1215=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00122 in 1,614,134 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P1215P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 3 hom. )

Consequence

KIF1B
NM_001365951.3 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:9

Conservation

PhyloP100: -2.89
Variant links:
Genes affected
KIF1B (HGNC:16636): (kinesin family member 1B) Predicted to enable microtubule binding activity and plus-end-directed microtubule motor activity. Predicted to be involved in chemical synaptic transmission; dense core granule cytoskeletal transport; and vesicle-mediated transport. Predicted to act upstream of or within mitochondrion transport along microtubule. Predicted to be located in cytoplasmic vesicle membrane and neuron projection. Predicted to be part of kinesin complex. Predicted to be active in several cellular components, including axon; dendrite; and microtubule. Implicated in Charcot-Marie-Tooth disease type 2A1; carcinoma (multiple); multiple sclerosis; neuroblastoma; and pheochromocytoma. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 1-10343244-G-A is Benign according to our data. Variant chr1-10343244-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 196788.We mark this variant Likely_benign, oryginal submissions are: {Benign=3, Uncertain_significance=1, Likely_benign=4}. Variant chr1-10343244-G-A is described in Lovd as [Benign]. Variant chr1-10343244-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-2.89 with no splicing effect.
BS2
High AC in GnomAd4 at 152 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
KIF1BNM_001365951.3 linkuse as main transcriptc.3645G>A p.Pro1215= synonymous_variant 34/49 ENST00000676179.1
KIF1BNM_001365952.1 linkuse as main transcriptc.3645G>A p.Pro1215= synonymous_variant 34/49
KIF1BNM_015074.3 linkuse as main transcriptc.3507G>A p.Pro1169= synonymous_variant 32/47

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
KIF1BENST00000676179.1 linkuse as main transcriptc.3645G>A p.Pro1215= synonymous_variant 34/49 NM_001365951.3 P1O60333-1

Frequencies

GnomAD3 genomes
AF:
0.000999
AC:
152
AN:
152174
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000786
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000472
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00165
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00110
AC:
277
AN:
251356
Hom.:
0
AF XY:
0.00113
AC XY:
153
AN XY:
135842
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.000694
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.00144
Gnomad FIN exome
AF:
0.000878
Gnomad NFE exome
AF:
0.00154
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.00125
AC:
1823
AN:
1461842
Hom.:
3
Cov.:
31
AF XY:
0.00127
AC XY:
926
AN XY:
727220
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.000715
Gnomad4 ASJ exome
AF:
0.000115
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00131
Gnomad4 FIN exome
AF:
0.000749
Gnomad4 NFE exome
AF:
0.00140
Gnomad4 OTH exome
AF:
0.00101
GnomAD4 genome
AF:
0.000998
AC:
152
AN:
152292
Hom.:
0
Cov.:
32
AF XY:
0.000980
AC XY:
73
AN XY:
74462
show subpopulations
Gnomad4 AFR
AF:
0.000241
Gnomad4 AMR
AF:
0.000785
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.000472
Gnomad4 NFE
AF:
0.00165
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00131
Hom.:
0
Bravo
AF:
0.00101
EpiCase
AF:
0.00202
EpiControl
AF:
0.00196

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesJan 21, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingInstitute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU DresdenNov 03, 2021- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2024KIF1B: BP4, BP7, BS1 -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not specified Benign:3
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 21, 2015- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 04, 2020This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Charcot-Marie-Tooth disease Benign:1
Benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Neuroblastoma Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Charcot-Marie-Tooth disease type 2 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 27, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.056
DANN
Benign
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147318592; hg19: chr1-10403302; COSMIC: COSV55809405; COSMIC: COSV55809405; API